Introduction {#section1-1553350618799553}
============

Autologous fat transfer (AFT) is becoming an increasingly popular procedure in various areas of plastic surgery. Whether used as a permanent filler in facial rejuvenation^[@bibr1-1553350618799553],[@bibr2-1553350618799553]^ or as a volume-enhancing technique in addition to oncoplastic or cosmetic surgery of the breast, much is written regarding the efficacy and safety as well as various techniques and satisfaction.^[@bibr3-1553350618799553][@bibr4-1553350618799553]-[@bibr5-1553350618799553]^ Thus, popularity and acceptance is growing. Vice versa, this acceptance leads to more and better research currently being conducted.^[@bibr6-1553350618799553]^ Regarding the AFT technique, the systematic review of Strong et al^[@bibr7-1553350618799553]^ recently showed higher retention rates in clinical studies with centrifugation---as opposed to sedimentation---and slow reinjection into less mobile areas. However, this same advantage could not be found in experimental animal and in vitro studies. Satisfaction rates among patients and surgeons are generally assessed with the use of Likert-type scales^[@bibr8-1553350618799553][@bibr9-1553350618799553][@bibr10-1553350618799553]-[@bibr11-1553350618799553]^ or validated questionnaires such as the Breast-Q.^[@bibr12-1553350618799553]^ Despite the advantages and rising confidence with the procedure, concerns about oncological safety remain, since several experimental studies show potential danger of interaction between adipose-derived stem cells and mammary epithelial cells as well as the potential of CD34+ progenitors in white adipose tissue to promote cancer progression.^[@bibr13-1553350618799553][@bibr14-1553350618799553]-[@bibr15-1553350618799553]^ Regardless of the increase in clinical acceptance of AFT, questions regarding the gold standard in AFT technique and oncological safety remain, partly because of the gap between clinical and basic science studies. One way to narrow the gap between the laboratory and clinical practices is by way of professional survey studies. Two survey studies among professionals are worth mentioning. Kaufman et al^[@bibr16-1553350618799553]^ in 2007 and Skillman et al^[@bibr17-1553350618799553]^ in 2013 performed a national survey concerning the use of AFT among 508 US, and 228 UK plastic surgeons, respectively. The former study reported mainly on the use of AFT in facial recontouring, and the latter mainly on the use in breasts, but both studies reported a general approval of the technique by surgeons as well as a high rate of surgeon-perceived patient satisfaction. The AFT technique used by the respondents---as reported in the study by Kaufman et al^[@bibr16-1553350618799553]^---rarely deviated from the methods discussed in the literature. Since this study dates from 2007 and reports on US respondents only, and given the recent developments in this field,^[@bibr18-1553350618799553][@bibr19-1553350618799553]-[@bibr20-1553350618799553]^ it is interesting to look at the current situation in Europe. The primary aim of this study is to report on the experience, practice, and opinion of plastic surgeons and breast surgeons in Europe with the AFT procedure in general and with special emphasis on breast surgery. The secondary aim is to highlight the possible differences between surgeons from different countries, thereby aiding the various national (plastic) surgery associations in finding important topics for upcoming meetings as well as surgeon education.

Methods {#section2-1553350618799553}
=======

An international, multicenter, cross-sectional, closed-ended format, study-specific questionnaire was created regarding AFT in general and with emphasis on breast surgery. The national plastic surgery associations of 10 European countries (The Netherlands, Belgium, Germany, Great Britain, France, Spain, Italy, Greece, Austria, and Switzerland) were contacted through email and, after introduction, asked for their participation in distributing this questionnaire among their members (active participation). When no reply was received, the organization was contacted on 2 additional occasions with a minimum of a 2-week interval by telephone during which the method and purpose of the study was explained and the organization was again asked for their participation in the study. Participating organizations distributed the questionnaire among its members with a reminder email following after 2 to 4 weeks. In the case of passive participation, no mediation by the national association was obtained in the distribution of the email (addresses). Instead, these were actively searched and collected by the first author through screening of the associations---"Member Information" online link, on the respective website. The questionnaire was constructed in SurveyGizmo, an online digital survey tool and translated in the following languages: Dutch, German, Spanish, Italian, and French by either a native-speaking colleague or an Internet-based translational service ([www.onehourtranslation.com](http://www.onehourtranslation.com)). The survey encompassed 36 multiple-choice questions, concerning 4 aspects of AFT, namely, background, AFT familiarity, AFT technique, and AFT opinion (see [Figure 1](#fig1-1553350618799553){ref-type="fig"}). A free-text section was provided at the bottom of the appropriate questions to allow respondents to add personal comments. The completion of the questionnaire was strictly voluntary and without compensation. The completed questionnaires were entered into a database (SPSS Inc, Chicago, IL) by one investigator (JG) for further analysis.

![Survey questions.\
Please note that---in question \#1---the participating countries exceeds the number of countries originally contacted. This is due to the fact the multiple respondents currently practiced in their home country after completing their residency abroad, a period in which they became members of their visiting countries' national plastic surgery association.](10.1177_1553350618799553-fig1){#fig1-1553350618799553}

Statistical Analyses {#section3-1553350618799553}
--------------------

The total number of estimated members of the participating countries (The Netherlands 425, Belgium 181, Germany 400, Great Britain 365, France 770, Spain 643, Italy 473, Austria 199, Switzerland 154, Greece 271)^[@bibr21-1553350618799553]^ was 3881. With this, a sample size of 350 is adequate to achieve a confidence level of 95% with a margin error or confidence interval T5% for the entire population.^[@bibr22-1553350618799553]^ Continuous data are presented as mean, standard deviation, and range. Categorical data are presented as counts or proportions. Differences between baseline characteristics of the respondents from different countries were assessed using *t* tests for continuous variables (age) and the Kruskal-Wallis test for ordinal variables (number of years of experience and number of procedures performed per year). Differences between both technical choices and attitude toward fat grafting were assessed in relation to country, years of experience (resident, 0-10, 10-20, and \>20 years of experience), and number of procedures performed per year (0-10, 10-20, and \>30 procedures performed per year). We used logistic regression in case of a binary response variable, ordinal regression in case of an ordinal response variable, and multinomial logistic regression in case of multiple response categories.

Results {#section4-1553350618799553}
=======

Details of the the countries participating, the method by which survey invitations were send (passive vs active), and the response rate are accessible through the online supplementary data ([Appendix A1](http://journals.sagepub.com/doi/suppl/10.1177/1553350618799553), available in the online version of the article). A total of 358 completed questionnaires were retrieved for analysis over a 10-month period (June 2016 to April 2017). [Table 1](#table1-1553350618799553){ref-type="table"} illustrates the baseline "respondent" demographics. The mean age was 46 years (SD = 10.8 years), with the majority being plastic surgeon (96.9%), followed by breast surgeons (1.7%) and other (1.4%, mostly German gynecologists). Eighty percent were consultants, with a majority having more than 20 years of practicing experience. Ninety percent disclosed having practiced AFT for general purposes (33.5%) or in addition to breast surgery (56.7%). The majority performed AFT alone (66.2%) in \<10 (26.5%) or between 10 and 30 (38.5%) procedures per year, and the vast majority considered himself or herself to be either experienced (41.6%) or moderately experienced (40.5%).

###### 

Baseline Characteristics.

![](10.1177_1553350618799553-table1)

  Question/Variable                                              Outcome: Mean (%)   Missing (%)                                                                                                                  
  -------------------------------------------------------------- ------------------- -------------------------- ---------------------------- ----------------- --------------- -------------- --------- --------- -----
  Age                                                            46 ±10.8            ---                                                                                                                          
  Specialty                                                                                                                                                                                                       ---
  • Plastic surgeon                                              347 (96.9)                                                                                                                                       
  • Breast surgeon                                               6 (1.7)                                                                                                                                          
  • Other                                                        5 (1.4)                                                                                                                                          
  Training                                                                                                                                                                                                        
  • Resident (per year of training)                              57 (15.9)           *1st*                      *2nd*                        *3rd*             *4th*           *5th*          *6th*     *Other*   ---
  5 (1.4)                                                        5 (1.4)             7 (2.0)                    11 (3.1)                     8 (2.2)           15 (4.2)        6 (1.6)                            
  • Registered medical specialist (experience)                   288 (80.4)          *\<5 years*                *5-10 years*                 *10-15 years*     *15-20 years*   *\>20 years*   1 (0.3)             
  43 (12.0)                                                      62 (17.3)           47 (13.1)                  44 (12.3)                    92 (25.7)                                                            
  • Other                                                        12 (3.4)                                                                                                                                         
  AFG familiarity                                                                    1 (0.3)                                                                                                                      
  • Familiar with AFG in general but not for breast procedures   120 (33.5)                                                                                                                                       
  • Familiar with AFG in general and for breast procedures       203 (56.7)                                                                                                                                       
  • Not familiar with AFG (never practiced)                      34 (9.5)                                                                                                                                         
  Number of AFG procedures per year                              *\<10*              *10-30*                    *30-50*                      *\>50*            35 (9.9)                                           
  95 (26.5)                                                      138 (38.5)          48 (13.4)                  42 (11.7)                                                                                         
  Perform AFG alone or with colleague                            *Alone*             *With colleague*           *With senior colleague*      *With resident*   36 (10.1)                                          
  237 (66.2)                                                     23 (6.4)            30 (8.4)                   32 (8.9)                                                                                          
  Experience (self-assessment)                                   *Experienced*       *Moderately experienced*   *Moderately unexperienced*   *Unexperienced*   36 (10.1)                                          
  149 (41.6)                                                     145 (40.5)          19 (5.3)                   9 (2.5)                                                                                           

Technique {#section5-1553350618799553}
---------

The harvest locations most often used were the abdomen (78.8%), the thigh (56.7%), and the flank (55.6%), with most respondents using wetting solution (50 mL of 1% lidocaine plus 1 mL of epinephrine \[1:1000\] plus 1 L of normal saline) as their primary choice for harvest site infiltration ([Table 2](#table2-1553350618799553){ref-type="table"}). Harvesting of fat was mostly performed by way of a liposuction device (41.9%), preferably through 3-mm cannulas (41.1%). When manual aspiration was used for harvesting (14.0%), most respondents did not know the actual diameter size of the cannula/needle. For preparation most respondents performed centrifugation (38.8%) besides washing of the fat (21.2%). Seventy-five percent of the respondents used a cannula to reinject the fat, aiming at 1 to 2 cc (30.7%) or \>4 cc (21.5%) of volume per pass. Overcorrection was used by most respondents (80.5%) ranging from 20% to 30% (28%) to more than 50% (3.1%). In breast surgery, more than half (52%) of the respondents grafted the subcutaneous plane in addition to both flap and implant reconstructions as well as the correction of local defects. For flap reconstructions, other planes most commonly grafted were the subglandular (31.8%) and the pectoral (29.9%) spaces with more than half of the respondents aiming at a total grafted volume of 50 to 100 cc (36.2%) or 100 to 150 cc (24.1%). For implant reconstruction/augmentation and for local defect correction (LDC), the preferred planes of reinjection were pectoral (21.8%) versus subglandular (20.9%) and intraglandular (29.9%) versus subglandular (29.1%) spaces, respectively. Methods for AFT take enhancement varied from none (33.8%) to rigottomies (21.5%) and preoperative and postoperative external expansion devices like the Breast Enhancement and Shaping System (BRAVA) in a few select cases (7.5% and 6.1%, respectively).

###### 

AFT Technique and Opinion.

![](10.1177_1553350618799553-table2)

  AFT Technique                                                                                                                                                                                                                                                                                                    
  ------------------------------------------------------------------------------------------------- ------------------------------ ------------------------------------------ -------------------------------------------------------- ------------------ --------------------- ------------ --------------------- -----------
  Harvest location^[a](#table-fn2-1553350618799553){ref-type="table-fn"}^                           *Gluteal*                      *Thigh*                                    *Flank*                                                  *Abdomen*          *Knee*                *Other*      ---                   
  25 (7.0)                                                                                          203 (56.7)                     199 (55.6)                                 282 (78.8)                                               92 (25.7)          15 (4.2)                                                 
  Anesthesia at harvest location                                                                    *0.5% Lido. + Epi*             *1% Lido. + Epi*                           *Wetting solution*                                       *Epinephrine*      *Other*               37 (10.3)                          
  24 (6.7)                                                                                          37 (10.3)                      186 (52.0)                                 26 (7.3)                                                 48 (13.4)                                                                   
  Harvesting technique                                                                              *Cannula + constant suction*   *Coleman technique (with micro-cannula)*   *Syringe + large-bore needle*                            *Other*            37 (10.3)                                                
  150 (41.9)                                                                                        98 (27.4)                      50 (14.0)                                  23 (6.4)                                                                                                                             
  Harvest Cannula diameter                                                                                                                                                                                                                                                                                         
  • Liposuction device                                                                              *1 mm*                         *2 mm*                                     *3 mm*                                                   *4 mm*             *Unknown*             *Other*      37 (10.3)             
                                                                                                    24 (6.7)                       72 (20.1)                                  147 (41.1)                                               39 (10.9)          25 (7.0)              14 (3.9)                           
  • Syringe                                                                                         *14 Gauge*                     *16 Gauge*                                 *18 Gauge*                                               *Unknown*          *Other*               43 (12.0)                          
                                                                                                    43 (12.0)                      64 (17.9)                                  40 (11.2)                                                147 (41.1)         21 (5.9)                                                 
  Fat preparation                                                                                   *None*                         *Washing*                                  *Centrifugation*                                         *Adding insulin*   *Decantation*         *Other*      53 (14.8)             
  12 (3.4)                                                                                          76 (21.2)                      139 (38.8)                                 2 (0,6)                                                  47 (13.1)          29 (8.1)                                                 
  Freeze fat (yes/nn)                                                                               *Yes*                          *No*                                       37 (10.3)                                                                                                                            
  10 (2.8)                                                                                          311 (86.9)                                                                                                                                                                                                     
  Anesthesia at injection site                                                                      *0.5% Lido. + Epi*             *1% Lido. + Epi*                           *Wetting solution*                                       *Epinephrine*      *None*                *Other*      45 (12.6)             
  19 (5.3)                                                                                          68 (19.0)                      34 (9.5)                                   3 (0.8)                                                  162 (45.3)         27 (7.5)                                                 
  Method of injection                                                                               *Cannula*                      *Needle*                                   *Ratchet gun*                                            *Other*            38 (10.6)                                                
  268 (74.9)                                                                                        45 (12.6)                      1 (0.3)                                    6 (1.7)                                                                                                                              
  Estimated volume of injection per pass                                                            *\<1 cc*                       *1-2 cc*                                   *2-4 cc*                                                 *\>4 cc*           *Unknown*             38 (10.6)                          
  68 (19.0)                                                                                         110 (30.7)                     43 (12.0)                                  77 (21.5)                                                22 (6.1)                                                                    
  Overcorrection (aim)                                                                              *None*                         *\<10%*                                    *10-20%*                                                 *20-30%*           *30-40%*              *40-50%*     *\>50%*               40 (11.2)
  30 (8.4)                                                                                          32 (8.9)                       96 (26.8)                                  99 (27.7)                                                40 (11.2)          10 (2.8)              11 (3.1)                           
  Grafted anatomical planes per indication^[a](#table-fn2-1553350618799553){ref-type="table-fn"}^   *Subcutaneous*                 *Intraglandular*                           *Subglandular*                                           *Pectoral*         *Subpectoral*         *Other*                            
  • Flap recon structions                                                                           186 (52.0)                     83 (23.2)                                  114 (31.8)                                               107 (29.9)         43 (12.0)             12 (3.4)                           
  • Implant recon struction/augmentation                                                            186 (52.0)                     66 (18.4)                                  75 (20.9)                                                78 (21.8)          25 (7.0)              7 (2.0)                            
  • Local defect corrections                                                                        186 (52.0)                     107 (29.9)                                 104 (29.1)                                               78 (21.8)          32 (8.9)              8 (2.2)                            
  AFT Technique                                                                                                                                                                                                                                                                                                    
  Question/Variable                                                                                 Outcome: Mean (%)              Missing (%)                                                                                                                                                                     
  • Flap reconstructions                                                                            21 (10.6)                      72 (36.2)                                  48 (24.1)                                                42 (21.1)          16 (8.0)                           159 (44.4)            
  • Implant reconstruction/augmentation                                                             39 (19.6)                      73 (36.7)                                  44 (22.1)                                                31 (15.6)          12 (6.0)                                                 
  • Local defect corrections                                                                        39 (19.6)                      95 (47.7)                                  47 (23.6)                                                17 (8.5)           1 (0.5)                                                  
  AFG enhancement^[a](#table-fn2-1553350618799553){ref-type="table-fn"}^                            *None*                         *BRAVA preop*                              *BRAVA postop*                                           *Rigottomies*      *Other*                                                  
  121 (33.8)                                                                                        27 (7.5)                       22 (6.1)                                   77 (21.5)                                                8 (2.2)                                                                     
  AFT Opinion                                                                                                                                                                                                                                                                                                      
  Question/Variable                                                                                 Outcome: Mean (%)              Missing (%)                                                                                                                                                                     
  General opinion (agreement with AFG)                                                              *Strongly agree*               *Agree*                                    *Somewhat agree*                                         *Undecided*        *Somewhat disagree*   *Disagree*   *Strongly disagree*   6 (1.7)
  171 (47.8)                                                                                        136 (38.0)                     28 (7.8)                                   6 (1.7)                                                  8 (2.2)            1 (0.3)               2 (0.6)                            
  Estimated volume retention \>6 months                                                             *\<30%*                        *40-50%*                                   *50-60%*                                                 *60-70%*           *70-80%*              *\>80%*      5 (1.4)               
  47 (13.1)                                                                                         84 (23.5)                      78 (21.8)                                  101 (28.2)                                               33 (9.2)           10 (2.8)                                                 
  Estimated cause of volume retention                                                               *Fat survival*                 *Replacement with scar tissue*             *Combination (fat survival + scar tissue replacement)*   *Other*            6 (1.7)                                                  
  179 (50.0)                                                                                        9 (2.5)                        150 (41.9)                                 14 (3.9)                                                                                                                             
  Estimated patient satisfaction with AFG                                                           *Excellent*                    *Good*                                     *Poor*                                                   5 (1.4)                                                                     
  184 (51.4)                                                                                        142 (39.7)                     27 (7.5)                                                                                                                                                                        

Abbreviations: Lido., lidocaine; Epi, epinephrine; wetting solution (50 mL of 1% lidocaine + 1 mL of epinephrine \[1:1000\] plus 1 liter of saline); BRAVA, Breast Enhancement and Shaping System; preop, preoperatively; postop, postoperatively.

Multiple answers possible.

Attitude {#section6-1553350618799553}
--------

The vast majority of respondents strongly agreed (47.8%) or agreed (38.0%) with the use of AFT for appropriate indications ([Table 2](#table2-1553350618799553){ref-type="table"}), with an almost equal distribution of respondents estimating the volume retention after 6 months to be in the range of 40% to 50% (23.5%), 50% to 60% (21.8%), or 60% to 70% (28.2%). There was a clear division in the opinion about causative factors when it comes to volume retention, with approximately half of the respondents attributing the results to fat survival (50%) or a combination of fat survival and scar tissue replacement (41.9%). Patient satisfaction as estimated by the surgeon was either excellent (51.4%) or good (39.7%) in the majority of respondents.

Differences Between Countries, Surgeon Experience, and AFT Procedure Performed per Year {#section7-1553350618799553}
---------------------------------------------------------------------------------------

Due to the small numbers of respondents for most participating countries (Denmark, Great Britain, Spain, Italy, Switzerland, Greece) a comparison could only be made between the Netherlands, Belgium, France, and Austria, with the remaining countries pooled together as "other." Furthermore, since no consensus and therefore gold standard currently exists regarding the AFT technique, no deviation thereof with regard to the various countries analyzed can be calculated. Therefore, the largest group of respondents (the Netherlands) was considered as an arbitrary baseline (see [Table 3a](#table3-1553350618799553){ref-type="table"}).

###### 

Outcome per Country, Years of Overall Experience, and AFT Procedures Performed Yearly^[a](#table-fn4-1553350618799553){ref-type="table-fn"}^.

![](10.1177_1553350618799553-table3)

  3a. Outcome per Country                                                                                                                                                                                                                                                                                                                                                                                                                                              
  ------------------------------------------------------------------- ---------------------------- --------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------
  No. of respondents (%)                                              141 (39.4)                   42 (11.7)                                                                                                             65 (18.2)                                                                                                             30 (8.4)                                                                                                                80 (22.3)
  Mean age ± SD                                                       42 ± 10                      46 ± 11 ↑[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                       51 ± 10 ↑[\*\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                   45 ± 10 ↑ns                                                                                                             50 ± 10 ↑[\*\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}
  Experience (%)                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  • Resident                                                          32.8                         5.0                                                                                                                   0.0                                                                                                                   10.3                                                                                                                    9.5
  • Specialist (0-10 years)                                           43.3                         40                                                                                                                    23.4                                                                                                                  41.4                                                                                                                    18.9
  • Specialist (10-20 years)                                          21.9                         27.5                                                                                                                  28.1                                                                                                                  31.0                                                                                                                    31.1
  • Specialist (\>20 years)                                           10.9                         27.5 ↑[\*\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                      48.4 ↑[\*\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                      17.2 ↑[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                            40.5 ↑[\*\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}
  AFT procedures/year (%)                                                                                                                                                                                                                                                                                                                                                                                                                                              
  • \<10                                                              47.9                         15.0                                                                                                                  18.5                                                                                                                  20.0                                                                                                                    21.1
  • 10-30                                                             38.5                         47.5                                                                                                                  35.4                                                                                                                  48.0                                                                                                                    51.3
  • \>30                                                              13.7                         37.5 ↑[\*\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                      46.2 ↑[\*\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                      32.0 ↑[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                            27.6 ↑[\*\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}
  Harvest location (%)                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  • Thigh                                                             55.3                         50.0 ↓[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                          72.3                                                                                                                  56.7                                                                                                                    50.0 ↓[\*](#table-fn7-1553350618799553){ref-type="table-fn"}
  • Abdomen                                                           75.2                         78.6                                                                                                                  81.5↓ [\*](#table-fn7-1553350618799553){ref-type="table-fn"}^[@bibr2-1553350618799553]^                               70.0                                                                                                                    86.3
  Local (donor site) anesthesia (%)                                                                                                                                                                                                                                                                                                                                                                                                                                    
  • Wetting solution                                                  69.8                         50.0                                                                                                                  34.4 ↓[\*\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                      64.0                                                                                                                    61.8
  Harvesting technique (%)                                                                                                                                                                                                                                                                                                                                                                                                                                             
  • Liposuction device                                                65.5                         57.5                                                                                                                  39.1 ↓[\*\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                      28.0 ↓[\*\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                        52.6 ↓[\*](#table-fn7-1553350618799553){ref-type="table-fn"}
  Liposuction cannula (%)                                                                                                                                                                                                                                                                                                                                                                                                                                              
  • \<2 mm                                                            43.8                         30.8                                                                                                                  24.2                                                                                                                  13.0                                                                                                                    39.1
  • \>3 mm                                                            56.2                         69.2                                                                                                                  75.8 ↑[\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                        87.0 ↑[\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                          60.9
  Preparation (%)                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  • Washing                                                           27.6                         31.3                                                                                                                  22.8                                                                                                                  20.0 ↓[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                            21.3
  • Centrifugation                                                    44.0                         43.8                                                                                                                  68.4 ↑[\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                        16.0 ↓[\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                          41.3
  Estimated volume per pass (%)                                                                                                                                                                                                                                                                                                                                                                                                                                        
  • \<1 cc                                                            26.5                         20.5                                                                                                                  5.1                                                                                                                   12.5                                                                                                                    36.5
  • 1-2 cc                                                            46.1                         38.5                                                                                                                  15.3                                                                                                                  54.2                                                                                                                    35.1
  • \>2 cc                                                            27.5                         41.0                                                                                                                  79.7 ↑[\*\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                      33.3                                                                                                                    28.4
  Overcorrection (%)                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  • None                                                              10.3                         0.05                                                                                                                  4.7                                                                                                                   20.0                                                                                                                    11.0
  • \<20                                                              42.2                         42.5                                                                                                                  32.8                                                                                                                  32.0                                                                                                                    45.2
  • 20-30                                                             26.7                         35.0                                                                                                                  37.5                                                                                                                  32.0                                                                                                                    30.1
  • \>30                                                              20.7                         17.5                                                                                                                  25.0 ↑[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                          16.0                                                                                                                    13.7
  *AFT + Flap reconstruction; injection planes (%)*                                                                                                                                                                                                                                                                                                                                                                                                                    
  • Subcutaneous                                                      54.6                         52.4                                                                                                                  46.2 ↓[\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                        53.3                                                                                                                    51.2 ↓[\*](#table-fn7-1553350618799553){ref-type="table-fn"}
  • Intraglandular                                                    25.5                         35.7                                                                                                                  26.2                                                                                                                  0.0                                                                                                                     18.8 ↓[\*](#table-fn7-1553350618799553){ref-type="table-fn"}
  • Subpectoral                                                       7.1                          19.0                                                                                                                  27.7 ↑[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                          3.3                                                                                                                     7.5
  *AFT + Implant reconstruction/augmentation; injection planes (%)*                                                                                                                                                                                                                                                                                                                                                                                                    
  • Subcutaneous                                                      55.3                         52.4 ↓[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                          47.7 ↓[\*\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                      50.0                                                                                                                    50.0 ↓[\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}
  *AFT + Local defect corrections; injection planes (%)*                                                                                                                                                                                                                                                                                                                                                                                                               
  • Subcutaneous                                                      53.9                         52.4                                                                                                                  46.2 ↓[\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                        56.7                                                                                                                    51.3 ↓[\*](#table-fn7-1553350618799553){ref-type="table-fn"}
  • Intraglandular                                                    38.3                         38.1                                                                                                                  24.6 ↓[\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                        16.7 ↓[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                            20.0 ↓[\*\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}
  *AFT + Flap reconstruction; estimated total injection volume*                                                                                                                                                                                                                                                                                                                                                                                                        
  • \<100                                                             62.4                         30.4                                                                                                                  9.4                                                                                                                   47.1                                                                                                                    52.4
  • 100-150                                                           25.9                         26.1                                                                                                                  15.6                                                                                                                  35.3                                                                                                                    21.4
  • \>150                                                             11.8                         43.5 ↑[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                          75.0 ↑[\*\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                      17.6                                                                                                                    26.2
  3b. Outcome per Year of Experience                                                                                                                                                                                                                                                                                                                                                                                                                                   
                                                                      Residents (Baseline)         \<10                                                                                                                  10-20                                                                                                                 \>20                                                                                                                    
  No. of respondents (%)                                              57 (15.9)                    104 (29.1)                                                                                                            91 (25.4)                                                                                                             92 (25.7)                                                                                                               
  Harvest location (%)                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  • Flank                                                             47.3                         59.6 ↓[\*](#table-fn7-1553350618799553){ref-type="table-fn"}^[c](#table-fn6-1553350618799553){ref-type="table-fn"}^   65.9 ↓[\*](#table-fn7-1553350618799553){ref-type="table-fn"}^[c](#table-fn6-1553350618799553){ref-type="table-fn"}^   48.9 ↓[\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}^[c](#table-fn6-1553350618799553){ref-type="table-fn"}^   
  Harvesting technique (%)                                                                                                                                                                                                                                                                                                                                                                                                                                             
  • Liposuction device                                                47.1                         47.5 ↑[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                          52.2 ↑[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                          62.9 ↑[\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                          
  *Liposuction cannula (%)*                                                                                                                                                                                                                                                                                                                                                                                                                                            
  • \<2 mm                                                            18.2                         30.3                                                                                                                  31.7                                                                                                                  44.4 ↑[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                            
  • \>3 mm                                                            81.8                         69.7                                                                                                                  68.3                                                                                                                  55.6                                                                                                                    
  Estimated volume per pass (%)                                                                                                                                                                                                                                                                                                                                                                                                                                        
  • \<1 cc                                                            23.1                         13                                                                                                                    25.0                                                                                                                  31.3                                                                                                                    
  • 1-2 cc                                                            38.5                         50.0                                                                                                                  33.0                                                                                                                  26.5                                                                                                                    
  • \>2 cc                                                            38.5                         37.0                                                                                                                  42.0                                                                                                                  42.2                                                                                                                    
  3c. Outcome per AFT Procedures Performed Yearly                                                                                                                                                                                                                                                                                                                                                                                                                      
                                                                      \<10 Proc./Year (Baseline)   10-30 Proc./Year                                                                                                      \>30 Proc./Year                                                                                                                                                                                                                               
  No. of respondents (%)                                              95 (26.5)                    138 (38.5)                                                                                                            90 (25.1)                                                                                                                                                                                                                                     
  Harvest location (%)                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  • Flank                                                             50.5                         61.6 ↑[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                          73.3 ↑[\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                                                                                                                                                
  Harvesting technique (%)                                                                                                                                                                                                                                                                                                                                                                                                                                             
  • Liposuction device                                                67.4                         50.0 ↓[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                          43.2 ↓[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                                                                                                                                                  
  AFT + Flap reconstruction; injection planes (%)                                                                                                                                                                                                                                                                                                                                                                                                                      
  • Subcutaneous                                                      53.7                         57.2                                                                                                                  62.2 ↑[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                                                                                                                                                  
  • Subglandular                                                      23.2                         34.8                                                                                                                  48.9 ↑[\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                                                                                                                                                
  • Pectoral                                                          20.0                         30.4                                                                                                                  51.1 ↑[\*\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                                                                                                                                              
  AFT + Implant reconstruction/augmentation; injection planes (%)                                                                                                                                                                                                                                                                                                                                                                                                      
  • Intraglandular                                                    15.8                         18.1                                                                                                                  28.9 ↑[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                                                                                                                                                  
  Subglandular                                                        15.8                         23.2                                                                                                                  31.1 ↑[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                                                                                                                                                  
  Pectoral                                                            16.8                         21.7                                                                                                                  35.6 ↑[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                                                                                                                                                  
  AFT + Local defect corrections; injection planes (%)                                                                                                                                                                                                                                                                                                                                                                                                                 
  • Subcutaneous                                                      52.6                         55.8                                                                                                                  65.6 ↑[\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                                                                                                                                                
  • Subglandular                                                      26.3                         29.7                                                                                                                  42.2 ↑[\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                                                                                                                                                  
  • Pectoral                                                          11.6                         22.5                                                                                                                  40.0 ↑[\*\*\*](#table-fn7-1553350618799553){ref-type="table-fn"}                                                                                                                                                                              

Abbreviation: AFT, autologous fat transfer.

The arrow (↓, ↑) indicates the value in which the country (3a), the experience (3b), or the AFT procedures performed yearly (3c) differs from the baseline (↓ = lower/less; ↑ = higher/more).

Arrows in the columns depict significant deviations from the baseline (column "Netherlands" in 3a, column "Residents" in 3b, and column "\<10 proc./year" in 3c).

Percentages are based on the data, significance levels are based on model estimates. Discrepancies between differences between percentages and the direction of the arrows are due to correction for other variables in the model.

Significance: ns = *P* \> .05. \**P* ⩽ .05. \*\**P* ⩽ .01. \*\*\**P* ⩽ .001.

The mean age of the Dutch respondents was significantly lower than that of other countries. The years of experience and number of AFT procedures performed yearly were higher in Belgium, France, Austria, and the other countries combined. Considering harvest locations, the thigh was significantly less used in Belgium and in the other countries combined, and the French respondents were less inclined to use the abdomen compared with the Dutch. The French and Austrian respondents seemed to prefer manual aspiration over a liposuction device and larger over smaller cannula sizes (\>3 vs \<2 mm) compared with the Dutch respondents. Furthermore, centrifugation was performed significantly more by the French and both centrifugation as well as washing significantly less by the Austrian surgeons, respectively. In addition to both flap and implant (breast) reconstruction as well as in correcting local (mammary) defects, the French respondents performed significantly less AFT in the subcutaneous plane, compared with the Dutch. In addition, so did both the French and the Austrian respondents when it came to intraglandular AFT for LDC. On the contrary, in addition to flap (breast) reconstructions, the French performed significantly more subpectoral fat injections. Finally, when asked about the amount of injected fat, both the French and the Belgian surgeons injected significantly more in addition to flap reconstruction than the Dutch surgeons.

[Table 3b](#table3-1553350618799553){ref-type="table"} and [3c](#table3-1553350618799553){ref-type="table"} stratify the number of respondents based on their experience and number of AFT procedures performed yearly. What stands out is both the harvesting location as well as technique and cannula size, besides the estimated injected volume. For example, we see that the flank as a harvesting location is more utilized by surgeons who perform more AFT procedures yearly, but is used less by surgeons with more overall clinical experience. On the contrary, the use of a liposuction device is less often used by both less experienced surgeons as well as surgeons who perform more AFT procedures per year. When looking at the different injection planes used, compared with the number of AFT procedures performed yearly, there seems to be a direct relationship between the two for all injection planes. In other words, the higher the numbers of AFT procedures performed yearly, the more injection planes are utilized by the surgeon. This holds true for intraglandular injections as well.

Discussion {#section8-1553350618799553}
==========

With the growing popularity of AFT among plastic surgeons, the number of AFT techniques and subsequently the patented AFT devices currently commercially available increases. The obvious attraction of the technique for both patients and surgeons comes forth from the desire to recycle fat tissue for a beneficial---often defect occupying---goal in reconstructive or augmentational surgery, hence the high surgeon and patient satisfaction rates that are generally reported in clinical studies and systematic reviews.^[@bibr23-1553350618799553],[@bibr24-1553350618799553]^ However, critics of AFT have strong arguments in pointing out the disadvantages, such as uncertainty regarding oncological and radiological safety in breast reconstruction/augmentation, besides unpredictable long-term results. In the United Kingdom, Germany, and France, clinical guidelines are now available to standardize the technique, aiding both clinical practice and reproducibility among scientific studies. In this light an overview of real-time clinical practice of AFT in Europe identifying differences between countries might aid further scientific studies in the search for the gold standard in AFT.

Despite an adequate overall response rate we found a low response rate per country, which may have been attributable to the headline of the survey invitation. This revealed the technical aspect of some of the questions, which might have discouraged surgeons who never practice AFT to respond. More than a quarter of the respondents had \>20 years of practicing experience and higher rates of these more experienced surgeons were found in all of the other countries compared with the Netherlands. This was probably attributable to the higher number of residents among the Dutch respondents. Our survey showed that breast surgery is still the most prominent indication for AFT in Europe. Also, the majority of surgeons performed AFT alone, in accordance with the findings of Skillman et al,^[@bibr17-1553350618799553]^ showing that while AFT can be time consuming, it is not a two-man's job necessarily. While AFT is a popular procedure, it is still not practiced often, with 26.5% of the respondents performing less than 10 AFT procedures per year and only 11.7% performing more than 50. These findings are in-line with Kaufman et al,^[@bibr16-1553350618799553]^ and although a longer learning curve might be the result of the relative few procedures performed, most surgeons considered themselves experienced.

The technique used remains one of the most heterogenic aspects of AFT, and while factors like harvesting technique and preparation seem to be rather uniform with the Coleman technique,^[@bibr25-1553350618799553],[@bibr26-1553350618799553]^ deviations thereof are becoming apparent. The abdomen is still the most prominent harvesting location overall. Second to this is the flank with even higher rates in the subgroup of respondents who perform more AFT procedures. In 2017 Europe, the vast majority (41.9%) of surgeons is using a liposuction device, which might be attributable to the time-saving properties of this technique. The French and the Austrian respondents used a liposuction device significantly less often than the Dutch population, which we hypothesized as possibly due to the higher level of experience (and Coleman technique adherence) of respondents from these countries. While randomized controlled trials comparing both methods are clearly needed, the recent systematic review by Shim et al^[@bibr27-1553350618799553]^ indicated a slight preference for manual aspiration, based on several small-cohort, retrospective and prospective studies.^[@bibr28-1553350618799553][@bibr29-1553350618799553][@bibr30-1553350618799553]-[@bibr31-1553350618799553]^ The preferred cannula size when using a liposuction device was 3 mm in 41%, with an equal percentage of respondents indicating not knowing the cannula size when using manual aspiration. This seems to be an area where improvement can be achieved, since several studies have indicated that the size of both the aspiration and injection cannula (\>3 mm to \<6 mm) matter significantly in terms of adipocyte viability.^[@bibr32-1553350618799553],[@bibr33-1553350618799553]^ Finally, in terms of injection technique and planes, half of the respondents aimed at injecting \<1 to 2 cc of fat, while overcorrecting 10% to 30%, in line with the Coleman method, with only the French injecting more. With regard to breast surgery, when AFT is used in addition to flap reconstruction, implant reconstruction or augmentation, and LDC, the subcutaneous plane was grafted most, followed by the subglandular and pectoral planes. What is interesting to see is that the intraglandular plane was grafted for all indications ranging from 18.4% in addition to implant reconstruction, to 30% in LDC. Even more interesting is the fact that intraglandular injection rates also seemed to be higher in more experienced surgeons based on the number of AFT procedures performed. Both the British and German clinical guidelines^[@bibr34-1553350618799553],[@bibr35-1553350618799553]^ currently strongly advise against the utilization of intraglandular AFT because of the possible carcinogenic differentiation of (remaining dormant) breast (cancer) cells.^[@bibr36-1553350618799553][@bibr37-1553350618799553]-[@bibr38-1553350618799553]^ While the number of respondents from the United Kingdom and Germany were too low to make any comparisons between countries, the Dutch plastic surgery association (NVPC) advises its members to adhere to the British guidelines and otherwise to keep up-to-date on the most recent scientific literature when performing AFT. The authors presume the same holds true for other countries, but nonetheless, there seems to be a gap between what is recommended and what is actually performed and herein might lay certain benefits from proper surgeon education when it comes to oncological safety of AFT.

The overall approval of the respondents with AFT in general as well as the surgeon-perceived patient satisfaction was considered high and seems in line with recent studies. The perception of what causes the eventual volume retention was either fat survival or a combination thereof with scar tissue formation, and further histological animal studies, preferably with long-term follow-up, are needed to substantiate the answer to this question. Finally, concerns with AFT in breast surgery are mainly regarding oncological safety, radiological safety, or practical issues. [Figure 2](#fig2-1553350618799553){ref-type="fig"} highlights the order in which these concerns troubled the respondents, illustrating that further studies should focus on the oncological and radiological safety of the technique.

![Respondents' concerns with the practice of autologous fat transfer (AFT) in order of most clinically important.\
Oncology: "The transplantation of adipose-derived stem cells and CD34+ progenitors in white adipose tissue poses a risk to promote cancer progression."\
Radiology: "The use of AFG in breast surgery impairs future radiological follow-up and breast cancer screening because of the frequent formation of fat necrosis and micro-/macro-calcifications."\
Practice: "The use of AFG in breast surgery is associated with unacceptable complications such as hematomas, infections, and the need for draining oily cysts/fat necrosis."](10.1177_1553350618799553-fig2){#fig2-1553350618799553}

Limitations {#section9-1553350618799553}
-----------

The information gathered by survey studies is dependent on honest answers. While the authors trust the intentions of the respondents, the accuracy of the answers given can---on a subconscious level---be colored by embarrassment, lack of memory, alacrity, or even boredom.^[@bibr39-1553350618799553]^ Furthermore, the survey was distributed among a select group of physicians, namely, plastic surgeons and breast surgeons who happened to be members of a plastic surgery association. Therefore, large numbers of---possible AFT practicing---surgeons (like members of the United Kingdom; Royal Colleges of Surgeons) were potentially missed and discrepancy between responders and nonresponders can create a selection bias. Finally, while the questions leave little room for interpretation, certain options like "somewhat agree" can mean different things to different individuals. Nonetheless, for the first time we were able to highlight differences in AFT technique between countries and levels of experience and point out the ongoing practice of intraglandular fat grafting in conjunction with breast surgery.

Conclusion {#section10-1553350618799553}
==========

This study provides the first overview of clinical practice regarding AFT in Europe and highlights important differences between countries that can aid in the focus of future studies as well as point out discrepancies in the physician adherence to clinical guidelines. The overall experience with AFT among respondents was moderate to high, with most applying its use in addition to breast surgery. Coleman's method is still the most widely used AFT technique but deviations thereof lay in the areas of harvesting technique and cannula sizes. The injection planes of AFT, in addition to breast surgery, are in order of most used: the subcutaneous, subglandular, and pectoral planes. However, despite prominent discouragement of the British and German clinical guidelines, intraglandular AFT still occurs in clinical practice today and this should be the focus of further surgeon education in Europe. Finally, it is the authors' hope that this "pilot study" into the realm of real-time reporting on the clinical practice of AFT may incite more *prospective* studies on the subject that may even one day lead to a European "Fat Grafting" database.
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